XENOVIEW is a Respiratory (inhalation) Gas in the Human Prescription Drug category. It is labeled and distributed by Polarean, Inc.. The primary component is Helium; Nitrogen; Xenon Xe-129.
Product ID | 80534-6350_d61a5389-0a84-465d-aacb-9407049f12d6 |
NDC | 80534-6350 |
Product Type | Human Prescription Drug |
Proprietary Name | XENOVIEW |
Generic Name | Xenon Xe 129 Hyperpolarized |
Dosage Form | Gas |
Route of Administration | RESPIRATORY (INHALATION) |
Marketing Start Date | 2022-12-23 |
Marketing Category | NDA / |
Application Number | NDA214375 |
Labeler Name | Polarean, Inc. |
Substance Name | HELIUM; NITROGEN; XENON XE-129 |
Active Ingredient Strength | 5652 L/1; L/1; L/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2024-12-31 |
Marketing Start Date | 2022-12-23 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
80534-1000 | XENOVIEW | xenon Xe 129 hyperpolarized |
80534-6350 | XENOVIEW | xenon Xe 129 hyperpolarized |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
XENOVIEW 90135724 not registered Live/Pending |
Polarean, Inc. 2020-08-25 |